Oxygen-ozone (O(2)-O(3)) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported

OBJECTIVE: This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O(2)-O(3)) mixture, via a process called Oxygen-Ozone- Immunoceutical Therapy. The methodology met the criteria of a novel, promising approach to treat successfully elderly C...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int Immunopharmacol
Autors principals: Franzini, Marianno, Valdenassi, Luigi, Ricevuti, Giovanni, Chirumbolo, Salvatore, Depfenhart, Markus, Bertossi, Dario, Tirelli, Umberto
Format: Artigo
Idioma:Inglês
Publicat: Elsevier B.V. 2020
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7414302/
https://ncbi.nlm.nih.gov/pubmed/32795898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.106879
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars